2013-2020年加拿大免疫监测项目ACTive中B群脑膜炎奈瑟菌分离株特征及H因子结合蛋白表达
研究分析了2013-2020年加拿大免疫监测项目ACTive收集的119株B群脑膜炎奈瑟菌侵袭性分离株,检测克隆复合群和fHbp肽及表面表达。CC-269和CC-41/44占75.6%,肽15在2015年前最流行但之后显著下降,90.8%分离株fHbp表面表达达到与MenB-FHbp疫苗保护相关的水平。
要点
- CC-269(48株)和CC-41/44(42株)占所有分离株的75.6%。
- 肽15在2015年前占比47.4-53.9%,之后降至0-22.1%。
- 90.8%分离株fHbp表面表达水平与MenB-FHbp保护相关。
核心结论
- 2013-2020年CC-269和CC-41/44占主导,肽15在2015年后显著下降,多数分离株fHbp表达水平与疫苗诱导保护相关,作者认为更广年龄授权可能增加NmB疾病预防。
研究设计与样本
- 研究通过加拿大免疫监测项目ACTive监测网络收集2013至2020年引起侵袭性脑膜炎球菌病的NmB菌株,共分析119株分离株,检测克隆复合群(CC)、fHbp肽及使用脑膜炎球菌抗原表面表达(MEASURE)法检测fHbp表面表达。
主要发现
- 119株分离株中118株编码全长fHbp,CC-269(48株)和CC-41/44(42株)占所有分离株的75.6%。
- 肽15在2015年前最流行(47.4-53.9%),之后降至0-22.1%。
- 总体fHbp表面表达中位数为4270 MFI(IQR 2132-14,462);肽15(中位数18,446,IQR 14,462-22,170)和肽210(中位数28,306,IQR 24,935-31,678)表面表达最高。
- 90.8%分离株fHbp表面表达达到与MenB-FHbp保护相关的水平。
临床怎么用
- 作者认为更广的疫苗年龄授权可能增加NmB疾病的预防。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Invasive meningococcal disease, caused by Neisseria meningitidis, remains a significant health threat. This study examined the genetic diversity of serogroup B (NmB) organisms and assessed the potential coverage offered by the MenB-FHbp vaccine, licensed for individuals aged 10-25 years. NmB vaccines have not yet been incorporated into most routine immunization programs in Canada, with the exception of campaigns to deal with specific outbreaks and targeted vaccination efforts for at-risk groups. METHODS: From 2013 to 2020, NmB strains causing invasive meningococcal disease were collected through the Canadian Immunization Monitoring Program ACTive surveillance network. Each isolate underwent analysis to determine clonal complex (CC) and factor-H binding protein peptide (fHbp), and fHbp surface expression using the Meningococcal Antigen Surface Expression (MEASURE) assay. RESULTS: Of 119 isolates analyzed, 118 coded for full-length fHbp. CC-269 (48 isolates) and CC-41/44 (42 isolates) represented 75.6 % of all isolates. fHbp peptide 15 was the most prevalent peptide up until 2015 (47.4-53.9 %) but declined to 0-22.1 % afterwards. Median fHbp surface expression overall was 4270 MFI (IQR 2132-14,462). Peptides 15 and 210 (both CC-269) had the highest fHbp surface expression: peptide 15 (median: 18,446, IQR: 14,462-22,170) and peptide 210 (median: 28,306, IQR 24,935-31,678). Notably, 90.8 % of isolates had fHbp surface expression at a level associated with MenB-FHbp protection. CONCLUSION: CC-269 and CC-41/44 predominated in 2013-2020. Notably, peptide 15, the most prevalent until 2015, declined significantly thereafter. The majority of isolates expressed fHbp at a level associated with vaccine-induced protection. A wider age authorization for the vaccine may result in increased prevention of NmB disease.
引用
- Meesters K, Sadarangani M, Clark SA, et al. Characterization of Canadian Neisseria meningitidis serogroup B isolates and factor-H binding protein expression, data from the Canadian Immunization Monitoring Program Active (IMPACT), 2013-2020. Vaccine. 2025. PMID: 40163976. doi:10.1016/j.vaccine.2025.127030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。